We've detected an Ad Blocker in your browser.

Please disable or pause the Ad Blocker and refresh the page to be able to register and access the website normally.


20-21 October



Please enter your email address

Having trouble logging in? Please email info@radcliffe-group.com

validation result

Please choose one of the options shown

Please enter your registration lead id

Please enter your registration session id

Please enter your successful log-in count

feed resp param id

Please choose one of the options shown

A global virtual event dedicated to the latest heart failure treatment strategies to support better patient outcomes


Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology are delighted to announce the return of e-SPACE Heart Failure to be held 20-21 October 2023.

Last year’s event brought together over 60 leading experts from around the world and a live global audience of thousands. Click here to watch e-SPACE Heart Failure 2022 on-demand.

e-SPACE Heart Failure 2023 will continue to deliver best-in-class free-to-access virtual education and will both optimise geographical reach whilst delivering both global and regional insight. A thoughtfully curated programme will support the exploration of how leading experts are implementing the new heart failure guidelines into clinical practice, as well as aiding the discovery of the latest information on patient profiling in heart failure for tailoring medical therapy.

Following on from the huge success of last year, this event will once again bring together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.

Underpinned by this combined expertise in educational content and delivery, and led by an international faculty of global standing, e-SPACE Heart Failure 2023 promises to be the widest reaching and most engaging to date.

Register now to join us.



Register Now

This live conference starts in:






Prof William Abraham

Ohio State University College of Medicine, Ohio, US

Dr Marianna Adamo

University of Brescia, Brescia, IT

Prof Stefan Anker

Charité Campus Virchow-Klinikum, Berlin, DE

Dr Javier de Juan Bagudá

University Hospital 12 de Octubre, Madrid, ES

Dr Maria Cecilia Bahit

INECO Neurociencias Oroño, Santa Fe, AR

Prof Ahmed Bennis

Ibn Rochd University Hospital, Casablanca, MA

Dr Deepak Bhatt

Mount Sinai Heart, New York, US

Prof Michael Böhm

Saarland University Hospital, Homburg, DE

Prof Frieder Braunschweig

Karolinska University Hospital, Stockholm, SE

Dr Jasper Brugts

Erasmus University Medical Centre, Rotterdam, NL

Dr Daniel Burkhoff

Cardiovascular Research Foundation, New York, US

Dr Javed Butler

Baylor Scott and White Research Institute, Texas, US

Dr Alicia Chan

Western HeartCare, Henley Beach, AU

Prof Ovidiu Chioncel

Institute for Cardiovascular Diseases C.C. Iliescu, Bucharest, RO

Prof John Cleland

University of Glasgow, Glasgow, UK

Prof Wolfram Doehner

Charité – Universitätsmedizin Berlin, Berlin, DE

Dr Joao Ferreira

University of Porto, Porto, PT

Dr Giulia Ferrannini

Karolinska Institute, Stockholm, SE

Prof Gerasimos Filippatos

National and Kapodistrian University of Athens, Athens, GR

Dr Marat Fudim

Duke University, Durham, US

Prof Ewa Jankowska

Wrocław Medical University, Wrocław, PL

Dr Mikhail Kosiborod

Saint Luke’s Mid America Heart Institute, Kansas City, US

Prof John McMurray

University of Glasgow, Glasgow, UK

Prof Marco Metra

University of Brescia, Brescia, IT

Dr Brenda Moura

Military Hospital, Porto, PT

Dr Milton Packer

Baylor University Medical Center, Texas, US

Prof Mark Petrie

University of Glasgow, Glasgow, UK

Prof Massimo Piepoli

IRCCS San Donato Polyclinic, San Donato Milanese, IT

Dr Ileana Pina

Thomas Jefferson University, Philadelphia, US

Prof Piotr Ponikowski

Wrocław Medical University, Wrocław, PL

Prof Giuseppe Rosano

St Georges Medical School, London, UK

Prof Stephan Rosenkranz

Heart Center at the University of Cologne, Cologne, DE

Prof Clara Ines Saldarriaga

CardioVID clinic, Medellin, CO

Dr Gianluigi Savarese

Karolinska Institute, Stockholm, SE

Prof Horst Sievert

CardioVascular Center Frankfurt, Frankfurt, DE

Dr Paul Sorajja

Minneapolis Heart Institute, Minneapolis, US

Dr Lynne Stevenson

Vanderbilt University Medical Center, Nashville, US

Dr John Teerlink

San Francisco Veterans Affairs Medical Center, San Francisco, US

Dr Muthiah Vaduganathan

Brigham and Women’s Hospital, Massachusetts, US

Dr Harriette van Spall

McMaster University, Hamilton, CA

Prof Stephan von Haehling

University Medicine Göttingen, Göttingen, DE

Prof Klaus Witte

RWTH University Hospital Aachen, Aachen, DE

Prof Yuhui Zhang

Cardiovascular Institute & Fuwai Hospital, Beijing, CN

Prof Shelley Zieroth

St. Boniface Hospital, Winnipeg, CA

Register now


(Please note this programme is subject to change)

Friday, 20 October 2023 (Day 1)
Time (ICT)
Time (CEST)
Time (BRT)
Part 1
Plenary session 1 – Recent guideline updates in HF

Chairs – Ahmed Bennis and Frieder Braunschweig
• ESC Guidelines update – Marco Metra
• New consensus on HF management of Australian clinicians – Alicia Chan
• Acute heart failure and valvular heart disease: a scientific statement of the Heart Failure Association – Ovidiu Chioncel
• Patient phenotyping in HFpEF – Stefan Anker

Plenary session 2 – GDMT in the clinical setting

Chairs – Michael Böhm and Frieder Braunschweig
• Foundational therapies in HFrEF – John McMurray
• Individualising GDMT implementation – Gianluigi Savarese
• Learnings from STRONG HF – Marianna Adamo

Part 2
Plenary session 3 – SGLT2s in clinical practice

Chairs – Stefan Anker and Clara Ines Saldarriaga
• SGLT2 inhibition in 2023: what’s exciting? – Milton Packer
• Early initiation to achieve rapid clinical benefits – Shelley Zieroth
• What about HF with improved ejection fraction? – Muthiah Vaduganathan
• Sotaglifozin: what’s new? – Deepak Bhatt

Plenary session 4 – Obesity and weight management in HF

Chairs – Mikhail Kosiborod and Stefan Anker
• Obesity and heart failure: epidemiology and mechanisms – Massimo Piepoli
• Weight gain / weight loss in HF – Giulia Ferranini
• The obesity paradox – Wolfram Doehner
• Overview of current therapeutic agents – Mark Petrie

Part 3
Plenary session 5 – Worsening and acute heart failure

Chairs – Gerasimos Filippatos and Ileana Pina
• HFA clinical statement on worsening HF – Marianna Adamo
• SGLT2s in patients hospitalised for acute HF – Piotr Ponikowski
• Vericiguat: the 5th pillar? – Javed Butler
• Omecamtiv Mecarbil: what’s next? – John Teerlink

Saturday, 21 October 2023 (Day 2)
Time (ICT)
Time (CEST)
Time (BRT)
Part 4
Plenary session 6 – Iron deficiency: the totality of evidence

Chairs – Piotr Ponikowski and Yuhui Zhang
• Iron deficiency and cardiovascular processes: what have we learnt so far? – Ewa Jankowska
• Latest data on ferric derisomaltose – John Cleland
• IV iron in HF: insights from recent meta analysis – Piotr Ponikowski
• What about dose? – Stephan von Haehling

Plenary session 7 – Managing comorbidities in HF

Chairs – Harriette van Spall and Brenda Moura
• Which comorbidities matter most?
• New MRAs for the management of patients with T2D and CKD – Gerasimos Filippatos
• Focus on hypertension – Michael Böhm
• Managing hyperkalemia – Joao Ferreira

Part 5
Plenary session 8 – Devices in HF: time to reassess their place?

Chairs – Javed Butler and Giuseppe Rosano
• CRT: a cornerstone of HF care
• Neuromodulation therapy for HFrEF – Javier de Juan Bagudá
• CCM: benefits of early implementation – Marat Fudim
• Interatrial shunts – William Abraham

Plenary session 9 – New technologies for HF management

Chairs – William Abraham and John Cleland
• Telemonitoring for heart failure – Lynne Stevenson
• MONITOR HF: what do we learn about haemodynamic monitoring? – Jasper Brugts
• Lung fluid remote management
• Highlights of innovation and technologies in HF – Daniel Burkhoff

Part 6
Plenary session 10 – Special populations

Chairs – Maria Cecilia Bahit and Horst Sievert
• Targeting FMR in HF – Klaus Witte
• Managing TR HF – Paul Sorajja
• Amyloid cardiomyopathy HF
• Secondary pulmonary hypertension in HF – Stephan Rosenkranz

Target Audience

  • Heart Failure Specialists
  • General Cardiologists
  • General Practitioners (GPs)
  • Nurses, Pharmacists, and other Allied Healthcare Professionals

If you’re interested in becoming an educational partner or sponsor at this event, please contact sales@radcliffe-group.com

About Translational Medicine Academy

Our ambition at the Translational Medicine Academy® (TMA) is to bring medical findings from bench to bedside and into the working lives of physicians and the care of patients. In seeking to improve therapeutic approaches, TMA works with its International Scientific Advisory Board on Critical Mission Areas® of public health importance in domains where there are educational shortcomings among physicians and unmet healthcare needs among patients.

Gathered around a Scientific Advisory Board of experts, the Translational Medicine Academy is an international non-profit Foundation with headquarter in Basel, and offices in Paris, and the US. TMA’s funding includes private donations from individuals and educational grants from governments, non-governmental organizations and corporations.

For more information on TMA, please visit www.tmacademy.org.

About Radcliffe Cardiology

We are Radcliffe, a knowledge network for the cardiovascular community.

We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.

We bring medical knowledge to life

From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.

Our work is underpinned by 3 core principles:

  • We build on the best science
  • We work hands-on with our community
  • We bring fresh thinking

Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.

For more information on Radcliffe Cardiology, please visit www.radcliffecardiology.com.

Please contact events@radcliffe-group.com should you have any queries.